Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00624221 · ClinicalTrials.gov registry record · NA
Study of Eye Bank Pre-cut Donor Grafts for Endothelial Keratoplasty
A NA study of Fuchs Endothelial Dystrophy and Corneal Edema, sponsored by Cornea Research Foundation of America.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT00624221 is a NA study of Fuchs Endothelial Dystrophy and Corneal Edema that has completed, run by Cornea Research Foundation of America. The registered enrollment target is 40 participants, below the 491-participant average among 7 other Fuchs Endothelial Dystrophy trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00624221, a NA study of Fuchs Endothelial Dystrophy and Corneal Edema, has completed, sponsored by Cornea Research Foundation of America.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Descemet's stripping with endothelial keratoplasty (DSEK) is a cornea-sparing transplant technique that replaces only the diseased endothelial cell layer of the patient's cornea. The DSEK technique requires lamellar dissection of the donor tissue prior to implantation in the patient's eye. The surgeon usually dissects the donor cornea with a microkeratome at the time of surgery. Recently some eye banks have begun to pre-cut the donor graft as an added service. The purpose of this study was to compare outcomes with eye bank pre-cut and surgeon-dissected donor grafts for DSEK.
Conditions Studied
Interventions
- PROCEDURE Descemet's stripping endothelial keratoplasty
Study Locations (1)
Indiana
- Cornea Research Foundation of America - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-01 |
| Est. Completion | 2007-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00624221
The ClinicalTrials.gov registry entry for NCT00624221 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 491-participant average among 7 other Fuchs Endothelial Dystrophy trials with a reported enrollment target (92% lower). The listed sponsor is Cornea Research Foundation of America, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Fuchs Endothelial Dystrophy appearing as the primary indexed condition, and to 1 intervention - of which Descemet's stripping endothelial keratoplasty is the first listed.
NCT00624221 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT00624221 about?
NCT00624221 is a clinical study titled "Study of Eye Bank Pre-cut Donor Grafts for Endothelial Keratoplasty". Descemet's stripping with endothelial keratoplasty (DSEK) is a cornea-sparing transplant technique that replaces only the diseased endothelial cell layer of the patient's cornea. The DSEK technique requires lamellar dissection of the donor tissue prior to implantation in the patient's eye. The surge...
What is the current status of trial NCT00624221?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2006-01. Estimated completion is 2007-11.
What conditions does trial NCT00624221 study?
This clinical trial studies the following conditions: Fuchs Endothelial Dystrophy, Corneal Edema.
What interventions are being tested in trial NCT00624221?
The interventions under investigation include: Descemet's stripping endothelial keratoplasty (PROCEDURE).
Who is sponsoring clinical trial NCT00624221?
This trial is sponsored by Cornea Research Foundation of America, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00624221 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fuchs Endothelial Dystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Plasma Rich in Growth Factors in Corneal Endothelial Transplantation
RECRUITING · NA
-
Ripasudil for Enhanced Corneal Clearing Following Descemet Membrane Endothelial Keratoplasty in Fuchs' Dystrophy
RECRUITING · Phase 2
-
DISCOVER Study: Microscope-integrated Intraoperative OCT Study
RECRUITING
-
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
RECRUITING
-
Descemet Endothelial Thickness Comparison Trial II
RECRUITING · Phase 3
-
Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.